COVID-19
As the world shifts toward a concept of social distancing as part of an attempt to protect against the novel coronavirus, new research is showing the virus that causes COVID-19 is quite stable on hard surfaces, and even in the air.
Approximately 100 cases of COVID-19 have been linked to a Biogen corporate meeting, as reported by a local media station in the Boston area.
‘Flatten the Curve’ is sure to become a phrase forever linked with COVID-19. It refers to doing all we can as individuals to slow the spread of COVID-19 so that all available resources can be used for those who need them most urgently.
Work in the age of COVID-19 is in flux. Restrictions change daily, and life sciences researchers are finding their work lives considerably different than they were a few short weeks ago.
Regeneron said it has identified hundreds of virus-neutralizing antibodies and intends to begin large-scale manufacturing by mid-April.
Restricting face-to-face interactions with people will go a long way in limiting the spread of the virus.
The $500,000 gift was in response to the COVID-19 outbreak and a need for more support, testing capacity and advancements.
As the world waits with bated breath for a treatment for COVID-19, all eyes are on Gilead Science’s antiviral drug remdesivir as a potential candidate.
Inside the U.S., the first clinical trial for a vaccine to the novel coronavirus that causes COVID-19 began today.
The companies intend to push the vaccine candidate into human trials by April of this year, subject to regulatory approval.
PRESS RELEASES